Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 104 participants.
Also called NCT03587558
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 104 participants
- Registry
-
NCT03587558
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT03587558. Randomized; no masking; primary purpose treatment. Start 2017-09-05 (actual); primary completion 2019-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract
- Acronym
- FOREVER
- Condition
- Ventricular Premature Complexes
- Condition
- Outflow Tract
- Condition
- Carvedilol
- Intervention (Drug)
- Carvedilol
- Intervention (Drug)
- Flecainide
- Lead sponsor
- Keimyung University Dongsan Medical Center
- Collaborator
- Chong Kun Dang Pharmaceutical Corp.
Record details
- Record id
cardio:ct-nct03587558- Content hash
0687e7595e2a890ab05cdc7a8d1684b0dc0521bb1859ad09d5f1f6afad2d375a